Concerning specific drivers of glioma progression, recurrent IDH mutant-noncodel gliomas presented an enrichment in CDKN2A homozygous deletions, with subsequent DNA aneuploidy and genetic instability that were associated with shorter OS [101]. The gene discussed is IDH2; the disease is central nervous system cancer.